Skip to main content
H.R. 5950 117th Congress House

Improving Patient Access to Care and Treatment Act

Official title: To amend the Controlled Substances Act to increase the number of days before which certain controlled substances for maintenance or detoxification treatment mu… Show full official titleShow less

Official title: To amend the Controlled Substances Act to increase the number of days before which certain controlled substances for maintenance or detoxification treatment must be administered, and for other purposes.

Introduced: December 2, 2021 Introduced by: Madeleine Dean Democratic · Pennsylvania See on congress.gov
Crime and Law Enforcement
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Nov 15, 2021
Referred to the Subcommittee on Health.
Nov 12, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 12, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 1, 2022

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Plain-English summary Congressional Research Service

Improving Patient Access to Care and Treatment Act

This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.

 Related & companion bills 2
  • HR 7666 Restoring Hope for Mental Health and Well-Being Act of 2022
  • S 3257 A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 6
All 6 Democratic 2 Republican 3
R
Bacon, Don
Nebraska · Dec 14, 2021
 D
Tonko, Paul
New York · Dec 2, 2021
Katko, John
· Nov 26, 2021
 R
Fitzpatrick, Brian K.
Pennsylvania · Nov 12, 2021
 D
Scanlon, Mary Gay
Pennsylvania · Nov 12, 2021
 R
Spartz, Victoria
Indiana · Nov 12, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5950: Improving Patient Access to Care and Treatment Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-5950/
MLA
"H.R. 5950: Improving Patient Access to Care and Treatment Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-5950/.
Bluebook (legal)
H.R. 5950, 117th Cong. (2026), https://openamerica.io/bill/117-HR-5950/.
Markdown link
[H.R. 5950: Improving Patient Access to Care and Treatment Act](https://openamerica.io/bill/117-HR-5950/)
Report a problem